| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13D/A | 2008-08-08 | ConPharm | LORUS THERAPEUTICS INC | 39,998,750 | 15.9% | EDGAR |
| SC 13D/A | 2008-02-04 | Abramson Herbert | LORUS THERAPEUTICS INC | 26,507,699 | 12.3% | EDGAR |
| SC 13D/A | 2007-11-27 | Abramson Herbert | LORUS THERAPEUTICS INC | 25,345,699 | 11.9% | EDGAR |
| SC 13D/A | 2007-10-31 | Abramson Herbert | LORUS THERAPEUTICS INC | 23,203,420 | 10.9% | EDGAR |
| SC 13D/A | 2007-09-20 | Abramson Herbert | LORUS THERAPEUTICS INC | 21,115,120 | 9.9% | EDGAR |
| SC 13D | 2007-08-02 | Abramson Herbert | LORUS THERAPEUTICS INC | 20,677,800 | 9.8% | EDGAR |
| SC 13D/A | 2007-07-11 | ConPharm | LORUS THERAPEUTICS INC | - | - | EDGAR |
| SC 13D/A | 2007-05-04 | ConPharm | LORUS THERAPEUTICS INC | 29,090,000 | 13.7% | EDGAR |
| SC 13D/A | 2006-08-31 | ConPharm | LORUS THERAPEUTICS INC | - | - | EDGAR |
| SC 13D | 2006-07-24 | ConPharm | LORUS THERAPEUTICS INC | 28,800,000 | 14.2% | EDGAR |
| SC 13G | 2006-02-27 | Abramson Herbert | LORUS THERAPEUTICS INC | 9,521,550 | 5.5% | EDGAR |